Global Penny Stock Spotlight: Tong Ren Tang Technologies And 2 Other Compelling Picks

Global markets have recently experienced a mix of volatility and gains, with geopolitical tensions and energy market fluctuations taking center stage. For investors interested in exploring beyond the major indices, penny stocks—despite their somewhat outdated name—continue to present intriguing opportunities. These smaller or newer companies can offer growth potential at lower price points, particularly when they possess strong financial foundations and resilience against broader market swings.

Below we spotlight a couple of our favorites from our exclusive screener.

Tong Ren Tang Technologies (SEHK:1666)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Tong Ren Tang Technologies Co. Ltd., along with its subsidiaries, is involved in the production and distribution of Chinese medicine products in Mainland China and Hong Kong, with a market cap of HK$4.61 billion.

Operations: The company's revenue is primarily generated from its main operations, "The Company," which accounts for CN¥4.02 billion, and Tong Ren Tang Chinese Medicine, contributing CN¥1.39 billion.

Market Cap: HK$4.61B

Tong Ren Tang Technologies Co. Ltd. has a robust financial position with CN¥10.2 billion in short-term assets exceeding both its short and long-term liabilities, and more cash than total debt, ensuring liquidity. Despite a new management team with an average tenure of 0.9 years, the company maintains high-quality earnings and pays a reliable dividend of 5.79%. However, recent negative earnings growth (-24.1%) contrasts with industry trends, and profit margins have decreased from 7.2% to 6.1%. A recent Product Sales Framework Agreement aims to bolster revenue through strategic partnerships for product supply within China until December 2028.

• Unlock comprehensive insights into our analysis of Tong Ren Tang Technologies stock in this financial health report.
• Examine Tong Ren Tang Technologies' earnings growth report to understand how analysts expect it to perform.

Oiltek International (SGX:HQU)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Oiltek International Limited is an investment holding company involved in supplying and providing engineering design and commissioning services for oil extraction equipment and plants across Asia, the United States, and Africa, with a market cap of SGD707.85 million.

Operations: The company generates revenue from three main segments: Edible & Non-Edible Oil Refinery (MYR134.37 million), Renewable Energy (MYR61.72 million), and Product Sales and Trading (MYR15.35 million).

Market Cap: SGD707.85M

Oiltek International Limited displays a strong financial foundation, with no debt and short-term assets of MYR181.5 million surpassing its short-term liabilities of MYR88 million. The company has experienced significant earnings growth, averaging 27.9% annually over five years, although recent growth slowed to 7.9%. Despite high volatility in share price, Oiltek maintains a high return on equity at 32% and improved net profit margins from 12.9% to 15.1%. Analysts anticipate further growth with forecasts suggesting a potential stock price increase of approximately 79.4%, although dividend payments have recently decreased slightly.

• Jump into the full analysis health report here for a deeper understanding of Oiltek International.
• Review our growth performance report to gain insights into Oiltek International's future.

Shenzhen Soling IndustrialLtd (SZSE:002766)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Shenzhen Soling Industrial Co., Ltd offers car-road-cloud solutions and has a market cap of CN¥3.09 billion.

Operations: Shenzhen Soling Industrial Co., Ltd has not reported any specific revenue segments.

Market Cap: CN¥3.09B

Shenzhen Soling Industrial Co., Ltd, with a market cap of CN¥3.09 billion, is navigating financial challenges as evidenced by its recent earnings report showing a net loss of CN¥18.17 million for the first quarter of 2026, compared to a net income previously. Despite being unprofitable, the company has reduced losses significantly over the past five years and improved its financial position from negative shareholder equity to positive. The company's short-term assets (CN¥844.3 million) comfortably cover both its short and long-term liabilities, indicating solid liquidity despite ongoing profitability issues and an inexperienced board.

• Click to explore a detailed breakdown of our findings in Shenzhen Soling IndustrialLtd's financial health report.
• Examine Shenzhen Soling IndustrialLtd's past performance report to understand how it has performed in prior years.

Make It Happen

• Explore the 3,622 names from our Global Penny Stocks screener here.
• Ready To Venture Into Other Investment Styles? AI is about to change healthcare. These 126 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com